Abstract
The interaction between sulbactam and imipenem was evaluated with four clinical isolates of Acinetobacter baumannii, including two isolates resistant to imipenem, one of which produced IMP-1 metallo-β -lactamase. Two isolates (one of which was imipenem-resistant) were sulbactam-resistant by undefined mechanisms. MICs were determined by standard broth microdilution methods. Time-kill assays with imipenem and sulbactam, alone or in combination at 0.5 × MIC and 1 × MIC, showed a synergic effect in all four isolates of A. baumannii after incubation for 0, 4, 8 and > 24 h at 35°C.
| Original language | English |
|---|---|
| Pages (from-to) | 1098-1101 |
| Number of pages | 4 |
| Journal | Clinical Microbiology and Infection |
| Volume | 10 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2004 Dec |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases
Fingerprint Dive into the research topics of 'Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii'. Together they form a unique fingerprint.
Cite this
Choi, J. Y., Soo Park, Y., Cho, C. H., Seon Park, Y., Shin, S. Y., Song, Y. G., Yong, D., Lee, K., & Kim, J. M. (2004). Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii. Clinical Microbiology and Infection, 10(12), 1098-1101. https://doi.org/10.1111/j.1469-0691.2004.00987.x